In focus · trending topic

Heritable Cardiomyopathies

3 stories · following the connections

MyoKardia Begins Patient Dosing in Phase 1b Clinical Study of MYK-491 in Dilated Cardiomyopathy Patients

By Nasdaq OMXFeb 14, 2018, 1:30 PM UTC

MyoKardia Announces Pricing of Proposed Public Offering of Common Stock

By Nasdaq OMXSep 27, 2016, 10:48 PM UTC

MyoKardia Announces Proposed Public Offering of Common Stock

By Nasdaq OMXSep 26, 2016, 8:48 PM UTC